Characteristics and Outcomes of Acinetobacter baumannii Infections in Critically Ill Patients with Cancer: A Matched Case-Control Study

Microbial Drug Resistance

Volumn 21, Issue 5, 2015, Pages 556-561

  Nazer, Lama H ^a   Kharabsheh, Asma ^a   Rimawi, Dalia ^a   Mubarak, Sawsan ^a   Hawari, Feras ^a  

^a KING HUSSEIN CANCER CENTER   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEPHALOSPORIN DERIVATIVE; COLISTIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER INFECTION; ADULT; AGE; ANTIBIOTIC SENSITIVITY; APACHE; ARTICLE; ARTIFICIAL VENTILATION; CANCER MORTALITY; CANCER PATIENT; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; GENDER; HEMATOLOGIC MALIGNANCY; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPTIC SHOCK; SOLID TUMOR; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGED; ANTIBIOTIC RESISTANCE; CRITICAL ILLNESS; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; JORDAN; MICROBIOLOGY; MIDDLE AGED; MORTALITY; NEOPLASMS; PATHOGENICITY; PATHOLOGY; SHOCK, SEPTIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGED; ANTI-BACTERIAL AGENTS; APACHE; CASE-CONTROL STUDIES; CRITICAL ILLNESS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INTENSIVE CARE UNITS; JORDAN; LENGTH OF STAY; MALE; MIDDLE AGED; NEOPLASMS; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84943252556     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2015.0032     Document Type: Article

References (22)

1. Albrecht, M.C., M.E. Griffith, C.K. Murray, K.K. Chung, E.E. Horvath, J.A. Ward, D.R. Hospenthal, J.B. Holcomb, and S.E. Wolf. 2006. Impact of Acinetobacter infection on mortality of burn patients. J. Am. Coll. Surg. 203:546-550.
2. Blot, S., K. Vandewoude, and F. Calordyn. 2003. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med. 29:471-475.
3. Caricato, A., L. Montini, G. Bello, V. Michetti, R. Maviglia, M.G. Bocci, G. Mercurio, S.M. Maggiore, and M. Antonelli. 2009. Risk factors and outcomes of Acinetobacter baumannii infection in severe trauma patients. Intensive Care Med. 35:1964-1969.
4. Dellinger, R.P., M.M. Levy, A. Rhodes, D. Annane, H. Gerlach, S.M. Opal, et al. 2013. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 39:165-228.
5. Erbay, A., A. Idil, M.G. Gozel, I. Mumcuoglu, and N. Balaban. 2009. Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections. Int. J. Antimicrob. Agents 34:575-579.
6. Falagas, M.E., I.A. Bliziotis, and I.I. Siempos. 2006. Attributable mortality of Acinetobacter baumannii in critically ill patients: a systematic review of matched cohort and case-control studies. Crit. Care 10:R48.
7. Fukuta, Y., R.R. Muder, M.E. Agha, L.G. Clarke, M.M. Wagener, A.M. Hensler, and Y. Doi. 2013.Risk factors for acquisition of multidrug-resistant Acinetobacter baumannii among cancer patients. Am. J. Infect. Control 41:1249-1252.
8. Garcia-Garmendia, J.L., C. Ortiz-Leyba, J. Garnacho-Montero, F.J. Jiménez-Jiménez, J. Monterrubio-Villar, and M. Gili-Miner. 1999. Mortality and increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit. Care Med. 27:1794-1799.
9. Hawari, F.I., T.I. Al Najjar, L. Zaru, W. Al Fayoumee, S.H. Salah, and M.Z. Mukhaimar. 2009. The effect of implementing high-intensity intensive care unit staffing model on outcome of critically ill oncology patients. Crit. Care Med. 37:1967-1971.
10. Joung, M.K., K.T. Kwon, C.I. Kang, H.S. Cheong, J.Y. Rhee, D.S. Jung, et al. 2010. Impact of inappropriate antimicrobial therapy on outcome in patients with hospitalacquired pneumonia caused by Acinetobacter baumannii. J. Infect. 61:212-218.
11. Lahmer, T., M. Messer, C. Schnappauf, A. Schmidt, R.M. Schmid, and W. Huber. 2014. Acinetobacter baumannii sepsis is fatal in medical intensive care unit patients: six cases and review of the literature. Anaesth. Intensive Care 42:666-668.
12. Lee, H.Y., C.L. Chen, S.R. Wu, C.W. Huang, and C.H. Chiu. 2014. Risk factors and outcome analysis of Acinetobacter baumannii complex bacteremia in critical patients. Crit. Care Med. 42:1081-1088.
13. Manchanda, V., S. Sanchaita, and N.P. Singh. 2010. Multidrug resistant Acinetobacter. J. Global Infect. Dis. 2:291-304.
14. Michalopoulos, A., and M.E. Falagas. 2010. Treatment of Acinetobacter infections. Expert Opin. Pharmacother. 11: 779-788.
15. Munoz-Price, L.S., and R.A. Weinstein. 2008. Acinetobacter infection. N. Engl. J. Med. 358:1271-1281.
16. Ng, T.M., C.B. Teng, D.C. Lye, and A. Apisarnthanarak. 2014. A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia. Infect. Control Hosp. Epidemiol. 35:49-55.
17. Rosolem, M.M., L.S. Rabello, T. Lisboa, P. Caruso, R.T. Costa, J.V. Leal, J.I. Salluh, and M. Soares. 2012. Critically ill patients with cancer and sepsis: clinical course and prognostic factors. J. Crit. Care 27:301-307.
18. Shorr, A.F., M.D. Zilberberg, S.T. Micek, and M.H. Kollef. 2014. Predictors of hospital mortality among septic ICU patients with Acinetobacter spp. bacteremia: a cohort study. BMC Infect. Dis. 14:572.
19. Sood, P., T. Seth, A. Kapil, V. Sharma, A. Dayama, S. Sharma, S. Kumar, A.K. Singh, P. Mishra, and M. Mahapatra. 2012. Emergence of multidrug resistant acinetobacter blood stream infections in febrile neutropenia patients with haematological cancers and bone marrow failure syndromes. J. Indian Med. Assoc. 110:439-444.
20. Sunenshine, R.H., M.O. Wright, L.L. Maragakis, A.D. Harris, X. Song, J. Hebden, et al. 2007. Multidrugresistant Acinetobacter infection mortality rate and length of hospitalization. Emerg. Infect. Dis.13:97-103.
21. Trecarichi, E.M., and M. Tumbarello. 2014. Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact. Curr. Opin. Infect. Dis. 27:200-210.
22. Turkoglu, M., E. Mirza, O.G. Tunçcan, G.U. Erdem, M. Dizbay, M. Yagci, G. Aygencel, and G. Türköz Sucak. 2011. Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: risk factors and impact on mortality. J. Crit. Care 26:460-467.